title: What is the optimal treatment for biphenotypic acute leukemia?
authors.forename: Changcheng
authors.initials: C
authors.lastname: Zheng
authors.forename: Jingsheng
authors.initials: J
authors.lastname: Wu
authors.forename: Xin
authors.initials: X
authors.lastname: Liu
authors.forename: Kaiyang
authors.initials: K
authors.lastname: Ding
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Cai
authors.forename: Weibo
authors.initials: W
authors.lastname: Zhu
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D015456:Leukemia, Biphenotypic, Acute / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D011379:Prognosis; D012074:Remission Induction; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D018952:Antigens, CD34; D009195:Peroxidase